
    
      The investigators collect and analyse results of anti-IL5/IL5R and anti-IgE therapies in
      asthma until October 2019.The investigators compare number of exacerbations, number of
      glucocorticoid courses, dose of per oral glucocorticoid, number of antibiotic courses, need
      of emergency care and hospitalizations because of asthma before use of biologicals and at the
      latest visits of the participants when using biologicals.
    
  